Clinical Trial Update: Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance avelumab immunotherapy in locally advanced or metastatic penile cancer (squamous cell carcinoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Cancer
• Penile Squamous Cell Carcinoma

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Penile Cancer, Penile Neoplasms | Phase 2 | Status: UNKNOWN